Rey Eric J. 4

4 · Arcadia Biosciences, Inc. · Filed Mar 16, 2018

Form 4

Period: 2018-03-14

DirectorPresident and CEO

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2018-03-15−250→ 35,719 total
Exercise: $44.88Exp: 2019-11-01→ Common Stock (250 underlying)
Sale
Common Stock
2018-03-15$60.00/sh−250$15,000→ 7,335 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-03-14−21,005→ 35,969 total
Exercise: $21.60Exp: 2018-06-30→ Common Stock (21,005 underlying)
Exercise/Conversion
Common Stock
2018-03-14$21.60/sh+21,005$453,708→ 28,340 total
Sale
Common Stock
2018-03-14$45.21/sh−21,005$949,615→ 7,335 total
Exercise/Conversion
Common Stock
2018-03-15$44.80/sh+250$11,200→ 7,585 total

Footnotes (3)

[F1]The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 6, 2017.
[F2]This transaction was executed in multiple trades at prices ranging from $38.00 to $49.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]The option is fully exercisable as of the date hereof.

Documents

1 file